Solventum to buy Acera Surgical for $725M
Solventum, the 3M health-care spinoff, said Friday it agreed to acquire regenerative wound care maker Acera Surgical for more than $725 million. It is Solventum’s first major deal since separating from 3M last year and signals expansion in advanced wound‑care products with potential impacts on the company’s Twin Cities operations.
Business & Economy
Health
📌 Key Facts
- Purchase price: $725 million+
- First major acquisition since Solventum’s 2024 spinoff from 3M
- Target: Acera Surgical, a regenerative wound care company